Teva’s generic epinephrine injection now available in limited quantity in the U.S.

PARSIPPANY, N.J. — Teva Pharmaceutical Industries announced the release of limited doses of the FDA-approved generic version of EpiPen (epinephrine injection, USP) Auto-Injector, 0.3 mg, in the U.S. Teva’s generic version of the EpiPen Jr (epinephrine injection, USP) Auto-Injector, 0.15 mg, and an additional supply of Teva’s generic version of the EpiPen (epinephrine injection, USP) Auto-Injector,